Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced…
biotricityMarch 12, 2024
Well Positioned to Enter US $1.56 Billion Canadian Cardiology Devices Market REDWOOD CITY, Calif., Feb…
biotricityFebruary 29, 2024
Topline growth with better quality revenue mix Increase in subscription revenue (fixed) vs usage based…
biotricityFebruary 21, 2024
REDWOOD CITY, Calif., Feb 19, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…
audavantFebruary 19, 2024
Company continues its shift to subscription-based revenue, prioritizing margin improvement and operational efficiency enhancements, on…
audavantFebruary 14, 2024
Company's growing data ecosystem supports the development of large data models for its future predictive…
audavantJanuary 23, 2024
Company reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward…
audavantNovember 14, 2023
Biotricity improves margins while lowering selling expenses and operating losses REDWOOD CITY, Calif., Nov 10,…
audavantNovember 10, 2023
Company further expands its current product portfolio, making it the most comprehensive Remote Patient and…
audavantOctober 31, 2023
